erythromycin |
114-07-8 |
Erythromycin A |
E-Mycin |
Erythrocin |
Abomacetin |
Ilotycin |
Erythromycinum |
Erymax |
Emgel |
Eritromicina |
Erythromycine |
Erythro-Statin |
Erythromycin base |
E-Glades |
Ery-Tab |
E-Base |
Eryacne |
ERYTHROMYCIN STEARATE |
Torlamicina |
Erycette |
Robimycin |
Bristamycin |
Erypar |
erythro |
Erythroguent |
Eritrocina |
Stiemycin |
Ermycin |
Erycen |
Erygel |
Aknin |
ERYC |
Pfizer-E |
(-)-ERYTHROMYCIN |
Theramycin Z |
Erythrocin stearate |
Ak-Mycin |
Erythromast 36 |
T-Stat |
Benzamycin |
MFCD00084654 |
Emycin |
Erytab |
Inderm |
Retcin |
UNII-63937KV33D |
CHEMBL532 |
erythromycin-A |
Dumotrycin |
Mephamycin |
CHEBI:42355 |
Sansac |
Wemid |
Eryc Sprinkles |
Erythra-Derm |
A/T/S |
Akne-Mycin |
63937KV33D |
R-P Mycin |
Endoeritrin |
Eritomicina |
Erythroderm |
Erytrociclin |
Paediathrocin |
Pharyngocin |
Proterytrin |
Acneryne |
Acnesol |
Aknemycin |
Derimer |
Deripil |
Erisone |
Eryacnen |
Erydermer |
Eryhexal |
Erysafe |
Iloticina |
Latotryd |
Lederpax |
Mercina |
Oftamolets |
Pantoderm |
Pantodrin |
Primacine |
Romycin |
Stiemicyn |
Tiloryth |
Tiprocin |
E-Solve 2 |
Emuvin |
Erecin |
Erymed |
Erytop |
NCI-C55674 |
AustriaS |
Eros |
Ery-maxin |
Erythro-Teva |
Sans-acne |
DSSTox_CID_2991 |
Erimycin-T |
Ery-Diolan |
Inderm Gel |
Del-Mycin |
Aknederm Ery Gel |
Udima Ery Gel |
Eryc 125 |
UNII-8HPH7ND0LN |
DSSTox_RID_76820 |
DSSTox_GSID_22991 |
Emu-Ve |
8HPH7ND0LN |
Skid Gel E |
(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)oxacyclotetradecane-2,10-dione |
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione |
Akne Cordes Losung |
ERY |
Ilosone (estolate) |
Ilotycin T.S. |
E-Mycin (base) |
Ery-Tab (base) |
Emu-V |
Ery-B |
E-Base (base) |
ERYC (base) |
C-Solve-2 |
N-Methylerythromycin A |
PCE Dispertab (base) |
Eryc-125 |
Eryc-250 |
Eritromicina INN-Spanish |
Erythromycine INN-French |
Erythromycinum INN-Latin |
Oftalmolosa Cusi Eritromicina |
Staticin (TN) |
Akne-mycin (TN) |
Erygel (TN) |
Eryc (TN) |
T-stat (TN) |
Pce (TN) |
SR-05000001618 |
Sentry AQ mardel maracyn |
9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione |
erthromycin |
Erythromycines |
NSC55929 |
CCRIS 9078 |
NSC-55929 |
HSDB 3074 |
NCGC00094670-01 |
Erythromycin USP:INN:BAN:JAN |
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yloxy-14-ethyl-7,12,13-trihydroxy-4-(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yloxy-3,5,7, |
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy}-14-ethyl-7,12,13-trihydroxy-4-{(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yloxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione |
CAS-114-07-8 |
Prestwick_205 |
EINECS 204-040-1 |
Erythromycin C-13 |
NSC 55929 |
Spectrum_000115 |
Spectrum_000659 |
AI3-50138 |
EM-A |
Prestwick3_000151 |
Spectrum2_000759 |
Spectrum2_001263 |
Spectrum4_000538 |
Spectrum5_001596 |
E0751 |
Erythromycin A, B + C |
EC 204-040-1 |
SCHEMBL2601 |
BSPBio_000282 |
BSPBio_002480 |
Erythromycin standard solution |
KBioGR_001175 |
KBioSS_000555 |
KBioSS_001139 |
MLS001066618 |
BIDD:GT0017 |
DivK1c_000294 |
DivK1c_000397 |
DivK1c_000702 |
SPECTRUM1500280 |
SPBio_000778 |
SPBio_001226 |
BPBio1_000312 |
GTPL1456 |
DTXSID4022991 |
Erythromycin (JP17/USP/INN) |
HMS500O16 |
KBio1_000294 |
KBio1_000397 |
KBio1_000702 |
KBio2_000555 |
KBio2_001139 |
KBio2_003123 |
KBio2_003707 |
KBio2_005691 |
KBio2_006275 |
J01FA01 |
Erythromycin (mixture of A,B,C) |
NINDS_000294 |
NINDS_000397 |
NINDS_000702 |
HMS1920M04 |
HMS2091D05 |
HMS2095O04 |
HMS3712O04 |
Pharmakon1600-01500280 |
ACT03320 |
HY-B0220 |
RKL10096 |
Tox21_111311 |
Tox21_111869 |
Tox21_300515 |
BDBM50344942 |
CCG-38992 |
LMPK04000006 |
NSC756759 |
ZINC85534336 |
Erythromycin, labeled with carbon-13 |
AKOS015895249 |
DB00199 |
MCULE-4566208867 |
NSC-756759 |
IDI1_000294 |
IDI1_000397 |
IDI1_000702 |
SMP1_000119 |
NCGC00179619-01 |
NCGC00179619-02 |
NCGC00179619-03 |
NCGC00254234-01 |
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yloxy-14-ethyl-7,12,13-trihydroxy-4-(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yloxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione |
82343-12-2 |
AC-12744 |
AC-12901 |
SMR000544946 |
Erythromycin, potency: >=850 mug per mg |
Erythromycin, tested according to Ph.Eur. |
SBI-0051368.P003 |
Erythromycin, N-demethyl-N-(methyl-11C)- |
Erythromycin, meets USP testing specifications |
C01912 |
D00140 |
E-3250 |
Erythromycin, plant cell culture tested, ~98% |
44496-EP2272846A1 |
44496-EP2275422A1 |
44496-EP2292608A1 |
44496-EP2305644A1 |
44496-EP2308866A1 |
44496-EP2311814A1 |
44496-EP2311828A1 |
44496-EP2380568A1 |
AB00051981_09 |
AB00051981_10 |
Erythromycin standard solution, 1 mg/mL in H2O |
Erythromycin, Biotechnology Performance Certified |
114E078 |
Erythromycin estolate impurity, free erythromycin- |
Q213511 |
SR-01000799155 |
Erythromycin, Antibiotic for Culture Media Use Only |
Erythromycin, BioReagent, suitable for cell culture |
SR-01000799155-2 |
SR-05000001618-1 |
SR-05000001618-2 |
BRD-K63550407-001-13-5 |
BRD-K63550407-028-03-9 |
Erythromycin (mixture of A,B,C) 100 microg/mL in Acetonitrile |
Erythromycin A, British Pharmacopoeia (BP) Reference Standard |
Erythromycin A, European Pharmacopoeia (EP) Reference Standard |
Erythromycin, United States Pharmacopeia (USP) Reference Standard |
Erythromycin, for microbiological assay, European Pharmacopoeia (EP) Reference Standard |
Erythromycin, Pharmaceutical Secondary Standard; Certified Reference Material |
(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-(2,6-Dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy-14-ethyl-7,12,13-trihydroxy-3,5,9,11,13-hexamethyl-6-3,4,6-trideoxy-3- |
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-14-ethyl-7,12,13-trihydroxy-6-3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyloxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione |
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yloxy-14-ethyl-7,12,13-trihydroxy-4-(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yloxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione |
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyloxan-2-yloxy-14-ethyl-7,12,13-trihydroxy-4-(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yloxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione |
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy}-14-ethyl-7,12,13-trihydroxy-4-{(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yloxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name) |
3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-(2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyloxyoxacyclotetradecane-2,10-dione |
215031-94-0 |